Andreas Willer
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 3
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 5
-
- Cancer Genomics and Diagnostics 4
- Virology top 10%
- HIV Research and Treatment 6
-
- Gastric Cancer Management and Outcomes 5
- Co-authors
- Andreas HochhausRüdiger HehlmannRüediger HehlmannGeorge YerganianPeter DuesbergSusanne SaußeleAlwin KraemerA Weißer
- Cited by
- HematologyGeneticsOncology
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Andreas Willer
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Hematology 356
- Genetics 198
- Oncology 326
- Cancer Research 156
- Virology 47
Countries citing papers authored by Andreas Willer
This map shows the geographic impact of Andreas Willer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Willer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Willer more than expected).
Fields of papers citing papers by Andreas Willer
This network shows the impact of papers produced by Andreas Willer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Willer. The network helps show where Andreas Willer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Willer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 23 | |
| 2 | 2009 | 64 | |
| 3 | 2007 | 82 | |
| 4 | 2005 | 18 | |
| 5 | 2004 | 13 | |
| 6 | 2003 | 17 | |
| 7 | 2002 | 50 | |
| 8 | 2000 | 99 | |
| 9 | 1999 | 24 | |
| 10 | 1999 | 8 | |
| 11 | 1999 | 207 | |
| 12 | 1997 | 13 | |
| 13 | Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group. | 1997 | 3 |
| 14 | 1997 | 148 | |
| 15 | 1994 | 19 | |
| 16 | 1993 | 2 | |
| 17 | 1993 | 21 | |
| 18 | 1992 | 6 | |
| 19 | 1990 | 6 | |
| 20 | 1984 | 4 |
About Andreas Willer
Andreas Willer is a scholar working on Virology, Hematology and Genetics, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Colorectal Cancer Treatments and Studies (7 papers), HIV Research and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Cancer Treatment and Pharmacology (5 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer Genomics and Diagnostics (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (356 citations), Genetics (198 citations) and Oncology (326 citations). Andreas Willer has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Andreas Hochhaus, Rüdiger Hehlmann, Rüediger Hehlmann, George Yerganian, Peter Duesberg, Susanne Saußele, Alwin Kraemer, A Weißer, Andreas Reiter and Nicholas C.P. Cross. Their work appears in journals such as Leukemia, Annals of Hematology, British Journal of Cancer, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.